Table of Contents Author Guidelines Submit a Manuscript
Gastroenterology Research and Practice
Volume 2015, Article ID 506390, 11 pages
http://dx.doi.org/10.1155/2015/506390
Research Article

The Protective Effect of Resveratrol on Concanavalin-A-Induced Acute Hepatic Injury in Mice

1Department of Gastroenterology, Shanghai Tenth People’s Hospital, Tongji University School of Medicine, Shanghai 200072, China
2The First Clinical Medical College of Nanjing Medical University, Nanjing 210029, China
3The First Affiliated Hospital of Soochow University, Suzhou 215006, China
4Department of General Surgery, Shanghai Tenth People’s Hospital, Tongji University School of Medicine, Shanghai 200072, China

Received 7 December 2014; Revised 1 April 2015; Accepted 2 May 2015

Academic Editor: Fabio Marra

Copyright © 2015 Yingqun Zhou et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Bishayee, A. S. Darvesh, T. Politis, and R. McGory, “Resveratrol and liver disease: from bench to bedside and community,” Liver International, vol. 30, no. 8, pp. 1103–1114, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. P. Muriel and Y. Rivera-Espinoza, “Beneficial drugs for liver diseases,” Journal of Applied Toxicology, vol. 28, no. 2, pp. 93–103, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. M. Heron, D. L. Hoyert, S. L. Murphy et al., Deaths: Final Data for 2006, National Vital Statistics Report, National Center for Health Statistics, Hyattsville, Md, USA, 2009.
  4. American Gastroenterological Association, The Burden of Gastrointestinal Diseases, American Gastroenterological Diseases, American Gastroenterological Association, Bethesda, Md, USA, 2001.
  5. S.-W. Hong, K. H. Jung, H.-M. Zheng et al., “The protective effect of resveratrol on dimethylnitrosamine-induced liver fibrosis in rats,” Archives of Pharmacal Research, vol. 33, no. 4, pp. 601–609, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. G. Oktem, A. Uysal, O. Oral et al., “Resveratrol attenuates doxorubicin-induced cellular damage by modulating nitric oxide and apoptosis,” Experimental and Toxicologic Pathology, vol. 64, no. 5, pp. 471–479, 2012. View at Publisher · View at Google Scholar · View at Scopus
  7. J. A. Rubiolo, G. Mithieux, and F. V. Vega, “Resveratrol protects primary rat hepatocytes against oxidative stress damage: activation of the Nrf2 transcription factor and augmented activities of antioxidant enzymes,” European Journal of Pharmacology, vol. 591, no. 1–3, pp. 66–72, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. M. Maccarrone, T. Lorenzon, P. Guerrieri, and A. F. Agrò, “Resveratrol prevents apoptosis in K562 cells by inhibiting lipoxygenase and cyclooxygenase activity,” European Journal of Biochemistry, vol. 265, no. 1, pp. 27–34, 1999. View at Publisher · View at Google Scholar · View at Scopus
  9. J. Martinez and J. J. Moreno, “Effect of resveratrol, a natural polyphenolic compound, on reactive oxygen species and prostaglandin production,” Biochemical Pharmacology, vol. 59, no. 7, pp. 865–870, 2000. View at Publisher · View at Google Scholar · View at Scopus
  10. S. Shishodia and B. B. Aggarwal, “Resveratrol: a polyphenol for all seasons,” in Resveratrolin Health and Disease, B. B. Aggarwal and S. Shishodia, Eds., pp. 1–16, CRC Press, Boca Raton, Fla, USA, 2006. View at Google Scholar
  11. P. Saiko, A. Szakmary, W. Jaeger, and T. Szekeres, “Resveratrol and its analogs: defense against cancer, coronary disease and neurodegenerative maladies or just a fad?” Mutation Research, vol. 658, no. 1-2, pp. 68–94, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. A. Bishayee, “Cancer prevention and treatment with resveratrol: from rodent studies to clinical trials,” Cancer Prevention Research, vol. 2, no. 5, pp. 409–418, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. C. D. Mann, C. P. Neal, G. Garcea, M. M. Manson, A. R. Dennison, and D. P. Berry, “Phytochemicals as potential chemopreventive and chemotherapeutic agents in hepatocarcinogenesis,” European Journal of Cancer Prevention, vol. 18, no. 1, pp. 13–25, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. G. Şener, H. Z. Toklu, A. Ö. Şehirli, A. Velioğlu-Öğünç, S. Çetinel, and N. Gedik, “Protective effects of resveratrol against acetaminophen-induced toxicity in mice,” Hepatology Research, vol. 35, no. 1, pp. 62–68, 2006. View at Publisher · View at Google Scholar · View at Scopus
  15. A. Kasdallah-Grissa, B. Mornagui, E. Aouani et al., “Protective effect of resveratrol on ethanol-induced lipid peroxidation in rats,” Alcohol and Alcoholism, vol. 41, no. 3, pp. 236–239, 2006. View at Publisher · View at Google Scholar · View at Scopus
  16. E. Chávez, K. Reyes-Gordillo, J. Segovia et al., “Resveratrol prevents fibrosis, NF-κB activation and TGF-β increases induced by chronic CCl4 treatment in rats,” Journal of Applied Toxicology, vol. 28, no. 1, pp. 35–43, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. P. Vitaglione, B. Ottanelli, S. Milani, F. Morisco, N. Caporaso, and V. Fogliano, “Dietary trans-resveratrol bioavailability and effect on CCl 4-induced liver lipid peroxidation,” Journal of Gastroenterology and Hepatology, vol. 24, no. 4, pp. 618–622, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. S. V. Fleig, S. S. Choi, L. Yang et al., “Hepatic accumulation of Hedgehog-reactive progenitors increases with severity of fatty liver damage in mice,” Laboratory Investigation, vol. 87, no. 12, pp. 1227–1239, 2007. View at Publisher · View at Google Scholar · View at Scopus
  19. J. K. Sicklick, Y.-X. Li, A. Melhem et al., “Hedgehog signaling maintains resident hepatic progenitors throughout life,” The American Journal of Physiology—Gastrointestinal and Liver Physiology, vol. 290, no. 5, pp. G859–G870, 2006. View at Publisher · View at Google Scholar · View at Scopus
  20. Y. Jung, K. D. Brown, R. P. Witek et al., “Accumulation of Hedgehog-responsive progenitors parallels alcoholic liver disease severity in mice and humans,” Gastroenterology, vol. 134, no. 5, pp. 1532–1543, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. Y. Jung, S. J. McCall, Y.-X. Li, and A. M. Diehl, “Bile ductules and stromal cells express hedgehog ligands and/or hedgehog target genes in primary biliary cirrhosis,” Hepatology, vol. 45, no. 5, pp. 1091–1096, 2007. View at Publisher · View at Google Scholar · View at Scopus
  22. J. A. Lowrey, G. A. Stewart, S. Lindey et al., “Sonic hedgehog promotes cell cycle progression in activated peripheral CD4+ T lymphocytes,” Journal of Immunology, vol. 169, no. 4, pp. 1869–1875, 2002. View at Publisher · View at Google Scholar · View at Scopus
  23. G. A. Stewart, J. A. Lowrey, S. J. Wakelin et al., “Sonic hedgehog signaling modulates activation of and cytokine production by human peripheral CD4+ T cells,” Journal of Immunology, vol. 169, no. 10, pp. 5451–5457, 2002. View at Publisher · View at Google Scholar · View at Scopus
  24. R. P. Witek, L. Yang, R. Liu et al., “Liver cell-derived microparticles activate hedgehog signaling and alter gene expression in hepatic endothelial cells,” Gastroenterology, vol. 136, no. 1, pp. 320.e2–330.e2, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. L. Yang, Y. Wang, H. Mao et al., “Sonic hedgehog is an autocrine viability factor for myofibroblastic hepatic stellate cells,” Journal of Hepatology, vol. 48, no. 1, pp. 98–106, 2008. View at Publisher · View at Google Scholar · View at Scopus
  26. S. S. Choi, A. Omenetti, R. P. Witek et al., “Hedgehog pathway activation and epithelial-to-mesenchymal transitions during myofibroblastic transformation of rat hepatic cells in culture and cirrhosis,” The American Journal of Physiology—Gastrointestinal and Liver Physiology, vol. 297, no. 6, pp. G1093–G1106, 2009. View at Publisher · View at Google Scholar · View at Scopus
  27. Y. Zhou, W. Dai, C. Lin et al., “Protective effects of necrostatin-1 against concanavalin A-induced acute hepatic injury in mice,” Mediators of Inflammation, vol. 2013, Article ID 706156, 15 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  28. M. Shen, J. Lu, P. Cheng et al., “Ethyl pyruvate pretreatment attenuates concanavalin A-induced autoimmune hepatitis in mice,” PLoS ONE, vol. 9, no. 2, Article ID e87977, 2014. View at Publisher · View at Google Scholar · View at Scopus
  29. K. Chen, J. Li, J. Wang et al., “15-Deoxy-γ12,14-prostaglandin J2 reduces liver impairment in a model of ConA-induced acute hepatic inflammation by activation of PPARγ and reduction in NF-κB activity,” PPAR Research, vol. 2014, Article ID 215631, 10 pages, 2014. View at Publisher · View at Google Scholar
  30. P. Cheng, W. Dai, F. Wang et al., “Ethyl pyruvate inhibits proliferation and induces apoptosis of hepatocellular carcinoma via regulation of the HMGB1-RAGE and AKT pathways,” Biochemical and Biophysical Research Communications, vol. 443, no. 4, pp. 1162–1168, 2014. View at Publisher · View at Google Scholar · View at Scopus
  31. A. Varthaman, J. Khallou-Laschet, M. Clement et al., “Control of T cell reactivation by regulatory Qa-1-restricted CD8+ T cells,” Journal of Immunology, vol. 184, no. 12, pp. 6585–6591, 2010. View at Publisher · View at Google Scholar · View at Scopus
  32. D. S. El-Agamy, “Comparative effects of curcumin and resveratrol on aflatoxin B 1-induced liver injury in rats,” Archives of Toxicology, vol. 84, no. 5, pp. 389–396, 2010. View at Publisher · View at Google Scholar · View at Scopus
  33. L. Bujanda, M. García-Barcina, V. Gutiérrez-de Juan et al., “Effect of resveratrol on alcohol-induced mortality and liver lesions in mice,” BMC Gastroenterology, vol. 6, article 35, 2006. View at Publisher · View at Google Scholar · View at Scopus
  34. H. Ajamieh and N. C. Teoh, “Red wine coming up roses for intestinal ischemia reperfusion injury: role for resveratrol?” Journal of Gastroenterology and Hepatology, vol. 24, no. 11, pp. 1701–1709, 2009. View at Publisher · View at Google Scholar · View at Scopus
  35. A. Kasdallah-Grissa, B. Mornagui, E. Aouani et al., “Resveratrol, a red wine polyphenol, attenuates ethanol-induced oxidative stress in rat liver,” Life Sciences, vol. 80, no. 11, pp. 1033–1039, 2007. View at Publisher · View at Google Scholar · View at Scopus
  36. L. Bujanda, E. Hijona, M. Larzabal et al., “Resveratrol inhibits nonalcoholic fatty liver disease in rats,” BMC Gastroenterology, vol. 8, article 40, 2008. View at Publisher · View at Google Scholar · View at Scopus
  37. C. D. Guy, A. Suzuki, M. Zdanowicz et al., “Hedgehog pathway activation parallels histologic severity of injury and fibrosis in human nonalcoholic fatty liver disease,” Hepatology, vol. 55, no. 6, pp. 1711–1721, 2012. View at Publisher · View at Google Scholar · View at Scopus
  38. W. Mo, X. Xu, L. Xu et al., “Resveratrol inhibits proliferation and induces apoptosis through the hedgehog signaling pathway in pancreatic cancer cell,” Pancreatology, vol. 11, no. 6, pp. 601–609, 2012. View at Publisher · View at Google Scholar · View at Scopus
  39. A. Omenetti, S. Choi, G. Michelotti, and A. M. Diehl, “Hedgehog signaling in the liver,” Journal of Hepatology, vol. 54, no. 2, pp. 366–373, 2011. View at Publisher · View at Google Scholar · View at Scopus
  40. J. E. Hooper and M. P. Scott, “Communicating with hedgehogs,” Nature Reviews Molecular Cell Biology, vol. 6, no. 4, pp. 306–317, 2005. View at Publisher · View at Google Scholar · View at Scopus
  41. M. Varjosalo, S.-P. Li, and J. Taipale, “Divergence of hedgehog signal transduction mechanism between Drosophila and mammals,” Developmental Cell, vol. 10, no. 2, pp. 177–186, 2006. View at Publisher · View at Google Scholar · View at Scopus
  42. Y. H. Feng, W. L. Zhou, Q. L. Wu, X. Y. Li, W. M. Zhao, and J. P. Zou, “Low dose of resveratrol enhanced immune response of mice,” Acta Pharmacologica Sinica, vol. 23, no. 10, pp. 893–897, 2002. View at Google Scholar · View at Scopus
  43. H.-X. Wang, M. Liu, S.-Y. Weng et al., “Immune mechanisms of Concanavalin a model of autoimmune hepatitis,” World Journal of Gastroenterology, vol. 18, no. 2, pp. 119–125, 2012. View at Publisher · View at Google Scholar · View at Scopus
  44. J. M. Austyn and S. Gordon, “F4/80, a monoclonal antibody directed specifically against the mouse macrophage,” European Journal of Immunology, vol. 11, no. 10, pp. 805–815, 1981. View at Publisher · View at Google Scholar · View at Scopus
  45. B. G. Lopez, M. S. Tsai, J. L. Baratta, K. J. Longmuir, and R. T. Robertson, “Characterization of Kupffer cells in livers of developing mice,” Comparative Hepatology, vol. 10, article 2, 2011. View at Publisher · View at Google Scholar · View at Scopus
  46. K. Bisht, K.-H. Wagner, and A. C. Bulmer, “Curcumin, resveratrol and flavonoids as anti-inflammatory, cyto- and DNA-protective dietary compounds,” Toxicology, vol. 278, no. 1, pp. 88–100, 2010. View at Publisher · View at Google Scholar · View at Scopus